XNYS · Diagnostics & Research
Last stored close · Sep 18, 2026
Close · Sep 18, 2026
$421.63-1.88%
Model Target
available with Pro
Implied upside
vs the model target
Valuation methods
the methods behind the target
TickerWhale Score
64/100
Positive
Score components
TickerWhale View
Waters scores 64 out of 100 overall, which we rate positive. Technical is its strongest area and Valuation its weakest.
What helps
- Technical
- Quality & growth
- Risk
What to watch
- Valuation
Quality & growth
30%77Strong
- Revenue growth 52.5%
- EPS growth -63.9%
Valuation
25%23Weak
- P/E 249.2
- EV/Sales 9.9
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with Becton Dickinson's life science and diagnostics business, which increased its concentration in diagnostics and discovery-related life science tools.
#280 by market cap in our coverage · ~7,900 employees · Listed 1995-11-17 · www.waters.com
Price history
Intraday to five-year windows are free with an account
Members switch between 1D, 1M, 6M, 1Y, 2Y and 5Y and see the live price. Signed out, this is the one-year stored series the technicals below are computed from.
Market intelligence
Peer position
#34 / 139sector rank by TickerWhale Score
TickerWhale Score 64 vs sector average 55.1 (+8.9)
Revenue growth (industry)Top 5%
Gross margin (industry)Top 65%
Return on equity (industry)Top 76%
P/E (industry)Pricier than 93%
Technical analysis
our read · what classic indicators sayTickerWhale technical read
97/100Strong vs universe
Ranks 97th of 100 covered names on our technical composite — the composite itself scores 79/100 · 25% of the TickerWhale Score
Classic chart indicators
Strong Buy
5 buy · 1 sell · 2 neutral of 8 votes
TickerWhale rates WAT's technical setup strong — 97th percentile of the covered universe. Classic chart indicators lean buy, pointing the same way.
Moving averages
9 / 9constructive
- vs 200-day+16.6%
- vs 50-day+5.8%
Momentum
Mixed
- RSI (14)59 · neutral
- Stochasticsell
- CCIbuy
- Williams %Rneutral
Trend
Constructive
- ADX (14) trend strength24· trending
- MACD (12,26,9)buy(histogram 0.637)
How the classic verdict is reached
Moving averages (9) agree on buy — 9 buy vs 0 sell — and carry one vote between them.
Oscillators (7) vote individually: 4 buy · 1 sell · 2 neutral.
Result — 5 buy vs 1 sell of 8 votes = Strong Buy. Neutral votes never decide the verdict.
Fundamentals & valuation
2026-09-18 · revised_latestValuation multiples
- P/E (TTM)249.2
- P/S (TTM)8.9
- P/B2.7
- EV/EBITDA—
- EV/Sales9.9
- PEG—
Profitability & returns
- Gross margin50.9%
- Net margin3.6%
- ROE1.1%
- Debt/Equity0.33
Growth
- Revenue growth (YoY)52.5%
- EPS growth (YoY)-63.9%
Green favourable · red stretched — multiples and D/E vs industry peers, margins and growth vs absolute thresholds.
Market capitalisation — $41.4B
Fundamentals history
Reported statement totals across recent periods.
Fundamentals are stored revised/latest (ADR-009): each period reflects the most recent vendor refresh, NOT point-in-time as-reported values. Do not use this series to claim what was known on a past date.
Model Target
Model Target is a Pro feature
Scores, factors and technicals stay free. The model's price target is part of TickerWhale Pro.
The Model Target is a TickerWhale Pro feature
A target exists for this name — the model priced it in the latest nightly run. Pro members see the target, its range and the methods behind it; one name's target is free every trading day.
Or see the current free one: MU →
Peers
| Company | Score | Pulse | P/E | P/E fwd | P/B | EV/Sales | Price | Chg | Estimate | Upside | Rev. gr. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WATCurrentWaters | 64 | 79 | 249.2 | — | 2.7 | 9.9 | $421.63 | -1.88% | +52.5% | ||
| EXELExelixis | 81 | 80 | 17.6 | — | 8.2 | 6.1 | $58.36 | -0.22% | +9.2% | ||
| INCYIncyte | 81 | 76 | 16.2 | — | 4.1 | 3.8 | $125.31 | -1.81% | +26.9% | ||
| ACADAcadia Pharmaceuticals | 80 | 63 | 12.4 | — | 3.6 | 3.8 | $27.29 | -0.58% | +11.8% | ||
| OSCROscar Health Inc - | 78 | 67 | 19.5 | — | 5.2 | 0.5 | $32.13 | +0.47% | +43.1% | ||
| TGTXTG Therapeutics | 77 | 73 | 20.3 | — | 14.8 | 11.5 | $56.87 | +0.71% | +76.1% |
News, sentiment, the Street view and Ask Willy are free with an account
A free account shows the stories attached to this name, the Sentiment Signal breakdown, analyst consensus, the options read and the AI narration of the model output.